SNOA
Sonoma Pharmaceuticals Inc.
Halal Rating :
Last Price
$2.65
Last updated:
Market Cap
-
7D Change
2.71%
1 Year Change
1516.84%
Company Overview
Industries
Exchange
Next Earnings Date
Sonoma Pharmaceuticals Inc. is a specialty pharmaceutical company that develops and manufactures stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions. The company focuses on the development and commercialization of innovative healthcare solutions that are both safe and effective.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $3.58m | $4.43m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $3.39m | $4.56m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $3.44m | $4.85m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Sonoma Pharmaceuticals Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.